Matthew Benson
Pediatric Endocrinology · Orlando, FLNPI 1942358411
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Sanofi at 33.0% of the total. 2025 is the largest year on record at $11,630, 2.5 times the $4,725 reported in 2019. Among pediatric endocrinology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $451.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$10K
- Sanofi-aventis U.S. LLC$9K
- Tolmar Pharmaceuticals, Inc.$6K
- Arbor Pharmaceuticals, Inc.$4K
- AstraZeneca$900
- BETA Bionics, Inc.$565
- plus $927 from 13 others
Across 2,938 payments — averaging $160.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$378K
- Sanofi US Services Inc.$90K
- Tolmar, Inc.$3K
What the payments were for
- Consulting fees$17,40255%
- Speaking & faculty fees$8,10526%
- Travel & lodging$3,22810%
- Food & beverage$2,7329%
- Education$1490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 7 | $10,424 |
| Sanofi-aventis U.S. LLC | 10 | $9,008 |
| Tolmar Pharmaceuticals, Inc. | 7 | $5,872 |
| Arbor Pharmaceuticals, Inc. | 5 | $3,920 |
| AstraZeneca | 1 | $900 |
| BETA Bionics, Inc. | 6 | $565 |
| Novo Nordisk | 11 | $276 |
| Insulet Corporation | 6 | $129 |
| Amgen | 1 | $118 |
| Ultragenyx Pharmaceutical Inc. | 1 | $90 |
| AbbVie | 3 | $69 |
| Abbott | 3 | $63 |
| Ascendis Pharma Endocrinology Inc | 2 | $55 |
| Medtronic | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Biomarin Pharmaceutical Inc. | 1 | $20 |
| Rhythm Pharmaceuticals, Inc. | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$8,809
- ELIGARD$4,145
- Triptodur$3,895
- FENSOLVI$1,605
- iLet Bionic Pancreas$1,462
- Strensiq$900
- iLet Insulin Infusion Kit Inset$144
- iLet Insulin Infusion Kit Contact Detach$144
How this compares
$31,616 in reported general payments places this provider in the 90th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Orlando
- Joshua YangOrlando$846K
- Neha VyasOrlando$6K
- Erin GreenupOrlando$6K
- Jennifer VillarOrlando$3K
- Michelle Rivera-VegaOrlando$3K
- Penelope PauleyOrlando$3K
- Paul DesrosiersOrlando$3K
- Richard BanksOrlando$2K
- Katherine VelezOrlando$2K
- Shadi TabbaOrlando$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.